| Filed On | Filing |
|---|---|
| 16 Oct 2026 | Proxy statement: annual meeting on December 4, 2026 |
| 09 Sep 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
Extension provides additional time through March 1, 2027, as Iveda advances commercial execution across its AI and connected-technology portfolio |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | 10-Q |
| 15 May 2026 | SCHEDULE 13G/A |
| 15 May 2026 | 10-Q |
| 02 Apr 2026 | 424B3 |
| 02 Apr 2026 | 424B3 |
| 02 Apr 2026 | 424B3 |
| 31 Mar 2026 | 10-K |
| 06 Mar 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 25 Feb 2026 |
Form 4: Gillen Robert, Director
Acquired 100,000 Options (Right to Buy) (Disposition to Issuer) · Granted 100,000 Options (Right to Buy) |
| 25 Feb 2026 |
Form 4: Franco Alejandro, Director
Acquired 25,000 Options (Right to Buy) (Disposition to Issuer) · Granted 25,000 Options (Right to Buy) |
| 25 Feb 2026 |
Form 4: Brilon Robert J, Chief Financial Officer
Acquired 125,000 Options (Right to Buy) (Disposition to Issuer) · Granted 125,000 Options (Right to Buy) |
| 25 Feb 2026 |
Form 4: Ly David H., Director
Acquired 175,000 Options (Right to Buy) (Disposition to Issuer) · Granted 175,000 Options (Right to Buy) |
| 25 Feb 2026 |
Form 4: Farnsworth Joseph A., Director
Acquired 100,000 Options (Right to Buy) (Disposition to Issuer) · Granted 100,000 Options (Right to Buy) |
| 19 Feb 2026 | SCHEDULE 13G |
| 13 Feb 2026 | SCHEDULE 13G |
| 13 Feb 2026 | SCHEDULE 13G |
| 13 Feb 2026 | 8-K: Entry into a Material Definitive Agreement; Other Events |
Loading...
